Skip to main content
CTKB logo

CTKB · Cytek Biosciences, Inc. · Executive Compensation

Track CTKB — free
$5.92 +0.22 (+3.86%) At close · Nov 18 Play latest call Q3 2026 earnings call transcript
Market Cap
$774.24M
Shares
130.78M
Volume · Nov 18 1.05M Avg daily vol (3M) 1.27M

Named-executive compensation from the company's DEF 14A proxy statements — salary, bonus, stock and option awards, non-equity incentive, and the company-reported total per executive per fiscal year, exactly as disclosed in the Summary Compensation Table.

Fiscal 2025
Executive Total
Wenbin Jiang $5,120,061
William McCombe $2,460,979
Valerie Barnett $2,174,943
Ming Yan $1,457,420
Philippe Busque $1,021,730
Fiscal 2024
Executive Total
Wenbin Jiang $6,084,671
Valerie Barnett $2,410,489
Chris Williams $2,338,447
Ming Yan $1,856,550
William McCombe $1,689,261
Philippe Busque $1,004,760
Patrik Jeanmonod $758,171
Fiscal 2023
Executive Total
Wenbin Jiang $4,939,242
Ming Yan $3,070,122
Valerie Barnett $1,862,394
Patrik Jeanmonod $1,786,088
Allen Poirson $1,426,276
Fiscal 2022
Executive Total
Wenbin Jiang $3,914,142
Ming Yan $1,481,241
Valerie Barnett $1,415,968
Fiscal 2021
Executive Total
Wenbin Jiang $4,818,502
Ming Yan $2,639,777
Patrik Jeanmonod $2,550,715
Fiscal 2020
Executive Total
Wenbin Jiang $422,221
Patrik Jeanmonod $365,161
Ming Yan $357,802

Executive changes

Person Change Filed
Valerie Barnett
“Ms. Barnett’s separation is not due to any disagreement with the Company’s operations, policies or practices.”
Terminated 2026-06-25
Philippe Busque, Ph.D.
“Dr. Busque’s resignation is not due to any disagreement with the Company’s operations, policies or practices.”
Resigned 2026-06-02
Paul Christopher Williams Resigned 2024-09-12
William ("Bill") McCombe Appointed 2024-03-19
Chris Williams Appointed 2022-11-01
Vera Imper Appointed 2022-01-06

Leadership

Key facts CIK 1831915 CUSIP 23285D109 13F (30d) 155 filings 138 filers Visit website Investor relations